Basit öğe kaydını göster

dc.contributor.authorSavasan, S
dc.contributor.authorSengun, Z
dc.contributor.authorÖZBEK, Uğur
dc.contributor.authorOzgeneci, A
dc.contributor.authorZulfikar, B
dc.date.accessioned2021-03-03T14:58:32Z
dc.date.available2021-03-03T14:58:32Z
dc.date.issued1996
dc.identifier.citationSavasan S., Zulfikar B., Ozgeneci A., ÖZBEK U., Sengun Z., "Monosomy 7 myeloproliferative disease associated with neurofibromatosis type I: A case report", JOURNAL OF CHEMOTHERAPY, cilt.8, sa.3, ss.243-246, 1996
dc.identifier.issn1120-009X
dc.identifier.othervv_1032021
dc.identifier.otherav_3c84607e-d715-4c09-b2c8-93c31032cbd5
dc.identifier.urihttp://hdl.handle.net/20.500.12627/44596
dc.identifier.urihttps://doi.org/10.1179/joc.1996.8.3.243
dc.description.abstractA 7-year-old girl with neurofibromatosis type I (NF1) was diagnosed to have monosomy 7 myeloproliferative disease (Mo 7-MPD). Of the benign and malignant tumors that are encountered with increased incidence in NF1, those originating from the neural crest are frequent. However, tumors that do not originate from the neural crest may also be seen and among these, myeloid leukemias are prominent. Studies on NF1 patients with Mo 7-MPD and juvenile chronic myeloid leukemia (JCML) have suggested the role of the NF1 gene in the leukemogenesis. The relationship between monosomy 7 and hematological malignancies is already known. These finding are in agreement with the multistep development theory of cancer. In addition, our case is one of the very rare NF1 cases having father to daughter inheritance with a myeloid malignancy. We believe that cytogenetic and molecular genetic studies will contribute to further understanding of leukemogenesis.
dc.language.isoeng
dc.subjectGeneral Immunology and Microbiology
dc.subjectPharmacology
dc.subjectImmunology
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectHistology
dc.subjectPathology and Forensic Medicine
dc.subjectPharmacology (medical)
dc.subjectOncology
dc.subjectBiochemistry (medical)
dc.subjectPharmacy
dc.subjectDrug Guides
dc.subjectInfectious Diseases
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectBULAŞICI HASTALIKLAR
dc.subjectİmmünoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectONKOLOJİ
dc.subjectPATOLOJİ
dc.subjectBiyoloji ve Biyokimya
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectBiyokimya
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectCerrahi Tıp Bilimleri
dc.subjectPatoloji
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.titleMonosomy 7 myeloproliferative disease associated with neurofibromatosis type I: A case report
dc.typeMakale
dc.relation.journalJOURNAL OF CHEMOTHERAPY
dc.contributor.department, ,
dc.identifier.volume8
dc.identifier.issue3
dc.identifier.startpage243
dc.identifier.endpage246
dc.contributor.firstauthorID2495511


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster